Covid-19 may increase resistance to antibiotics

▴ covid19-may-increase-resistance-antibiotics
A team of researchers at Queen's University found that COVID-19 virus increased resistance to antibiotics.

With the rise in the number of cases of novel coronavirus infection all around the world, researchers and medical experts are in a race to develop a vaccine and are also testing current anti-viral and various other treatments for curing COVID-19, the disease caused by the novel corona-virus SARS-CoV-2, which presently has no cure.

A team of researchers from Queen's University in Belfast in Northern Island have, however observed a new problem associated with COVID-19, antimicrobial resistance. Antimicrobial or antibiotic resistance is another common problem faced by the healthcare systems of the world, and the team has notified of a sharp rise in the condition, related with the treatment and aftermath of the pandemic, as reported by news agency IANS.

Meanwhile yesterday, Prime Minister Narendra Modi interacted with 21 States and Union Territories through video conferencing. During his interaction, the Prime Minister observed that timely decisions taken to combat the pandemic have been effective in containing its spread in the country. He said, its early preparedness approach helped the country to chalk out measures to save many lives.


Mr. Modi said, when India's fight against COVID-19 will be analyzed in the future, the time will be remembered for how the Centre and States worked together to fight the pandemic. The Prime Minister said they have presented an example for cooperative federalism to the world. Mr. Modi said that even a single loss of life due to corona-virus is saddening and the nation should not lower its guard even during the unlock. He urged every citizen to strictly follow all necessary precautions including wearing masks, maintaining Do Gaj ki Doori and washing hands regularly with soap. Mr. Modi said, they have tried to save each and every life.


The Prime Minister said, even though India has a huge population, corona-virus has not assumed as life threatening a form as in the rest of the world. He said that health experts world over are praising the discipline shown by Indians, adding that the recovery rate in the country is now over 50 percent. He also noted that India is amongst the nations with the least deaths due to corona-virus.


The first part of the two-day interaction yesterday witnessed participation of States and Union Territories including Punjab, Assam, Kerala, Uttarakhand, Jharkhand, Chhattisgarh, Tripura, Himachal Pradesh, Chandigarh, Goa, Manipur, Nagaland, Ladakh, Puducherry, Arunachal Pradesh, Meghalaya, Mizoram, Andaman and Nicobar Islands, Dadra Nagar Haveli and Daman Diu, Sikkim and Lakshadweep.

Tags : #COVID-19 #Antibiotics

Related Stories

02 Aug

Sweet Poison: Heavy Metal Contamination in Chocolate

While chocolates and cocoa-based products are generally safe to consume in moderation, it is essential to be aware of the potential risks associated with heavy metal contamination.

View
18 Mar

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy.

View
17 Nov

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need for broader insurance coverage to ensure accessibility for a larger population.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
03 Nov

A New Hope for Sickle Cell Patients: Groundbreaking Gene Therapy Under FDA Review

Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying the patient's blood cells, the therapy targets the root cause of the disease, promoting the production of healthy haemoglobin.

View
23 Oct

Indian Medtech Startup Sigtuple Receives U.S. FDA approval; becomes India's 1st company in this space to earn the clearance

For all haematological disorders like blood cancers, infections, anaemia & allergies, the microscopic examination of the peripheral blood smear (PBS) is the gold standard test, but microscopy today is predominantly a manual process - necessitating a highly skilled pathologist to be present on-site.

View
06 Oct

Safety Concerns Arise: FDA Investigates Probiotic-Related Infant Death

Probiotics are live microorganisms believed to enhance health when consumed adequately, while they offer potential health benefits, this incident highlights the importance of careful consideration, especially in vulnerable populations like preterm infants.

View
05 Aug

FDA Approves Groundbreaking Postpartum Depression Oral Pill - Zurzuvae (Zuranolone)

Postpartum depression (PPD) affects countless new mothers worldwide, casting a shadow over what should be a joyful time in their lives. For years, healthcare professionals have been searching for an effective treatment for this debilitating condition. In a momentous development, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever postpartum depression oral pill, Zurzuvae (Zuranolone).

View
23 Feb

4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029

Latest Pharma news

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025